These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 38892278)
1. Microcurrent Therapy Mitigates Neuronal Damage and Cognitive Decline in an Alzheimer's Disease Mouse Model: Insights into Mechanisms and Therapeutic Potential. Kim EH; Lee WS; Kwon DR Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892278 [TBL] [Abstract][Full Text] [Related]
2. Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-β Plaque Burden. Suganuma T; Hatori S; Chen CK; Hori S; Kanuka M; Liu CY; Tatsuzawa C; Yanagisawa M; Hayashi Y J Alzheimers Dis; 2024; 99(4):1285-1301. PubMed ID: 38788074 [TBL] [Abstract][Full Text] [Related]
3. Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse Model. Ding J; Huang J; Yin D; Liu T; Ren Z; Hu S; Ye Y; Le C; Zhao N; Zhou H; Li Z; Qi X; Huang J Oxid Med Cell Longev; 2021; 2021():3298400. PubMed ID: 34777683 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer's disease. Ruganzu JB; Peng X; He Y; Wu X; Zheng Q; Ding B; Lin C; Guo H; Yang Z; Zhang X; Yang W Mol Immunol; 2022 Feb; 142():22-36. PubMed ID: 34959070 [TBL] [Abstract][Full Text] [Related]
6. Silencing of LRP1 Exacerbates Inflammatory Response Via TLR4/NF-κB/MAPKs Signaling Pathways in APP/PS1 Transgenic Mice. He Y; Ruganzu JB; Zheng Q; Wu X; Jin H; Peng X; Ding B; Lin C; Ji S; Ma Y; Yang W Mol Neurobiol; 2020 Sep; 57(9):3727-3743. PubMed ID: 32572761 [TBL] [Abstract][Full Text] [Related]
7. Gx-50 reduces β-amyloid-induced TNF-α, IL-1β, NO, and PGE2 expression and inhibits NF-κB signaling in a mouse model of Alzheimer's disease. Shi S; Liang D; Chen Y; Xie Y; Wang Y; Wang L; Wang Z; Qiao Z Eur J Immunol; 2016 Mar; 46(3):665-76. PubMed ID: 26643273 [TBL] [Abstract][Full Text] [Related]
8. Jiaohong pills attenuate neuroinflammation and amyloid-β protein-induced cognitive deficits by modulating the mitogen-activated protein kinase/nuclear factor kappa-B pathway. Zhang H; Cai W; Dong L; Yang Q; Li Q; Ran Q; Liu L; Wang Y; Li Y; Weng X; Zhu X; Chen Y Animal Model Exp Med; 2024 Jun; 7(3):222-233. PubMed ID: 38177948 [TBL] [Abstract][Full Text] [Related]
9. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease. Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease. Balducci C; Frasca A; Zotti M; La Vitola P; Mhillaj E; Grigoli E; Iacobellis M; Grandi F; Messa M; Colombo L; Molteni M; Trabace L; Rossetti C; Salmona M; Forloni G Brain Behav Immun; 2017 Feb; 60():188-197. PubMed ID: 27751869 [TBL] [Abstract][Full Text] [Related]
11. L-DOPA regulates neuroinflammation and Aβ pathology through NEP and ADAM17 in a mouse model of AD. Lee HJ; Nam J; Hwang JW; Park JH; Jeong YJ; Jang JY; Kim SJ; Jo AR; Hoe HS Mol Brain; 2024 Apr; 17(1):21. PubMed ID: 38685105 [TBL] [Abstract][Full Text] [Related]
12. Tooth Loss Induces Memory Impairment and Gliosis in App Knock-In Mouse Models of Alzheimer's Disease. Taslima F; Jung CG; Zhou C; Abdelhamid M; Abdullah M; Goto T; Saito T; Saido TC; Michikawa M J Alzheimers Dis; 2021; 80(4):1687-1704. PubMed ID: 33720883 [TBL] [Abstract][Full Text] [Related]
13. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease. Paouri E; Tzara O; Zenelak S; Georgopoulos S J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177 [TBL] [Abstract][Full Text] [Related]
14. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition. Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121 [TBL] [Abstract][Full Text] [Related]
15. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease. Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156 [TBL] [Abstract][Full Text] [Related]
16. Dynamic microglia alterations associate with hippocampal network impairments: A turning point in amyloid pathology progression. Pizzirusso G; Preka E; Goikolea J; Aguilar-Ruiz C; Rodriguez-Rodriguez P; Vazquez-Cabrera G; Laterza S; Latorre-Leal M; Eroli F; Blomgren K; Maioli S; Nilsson P; Fragkopoulou A; Fisahn A; Arroyo-García LE Brain Behav Immun; 2024 Jul; 119():286-300. PubMed ID: 38608739 [TBL] [Abstract][Full Text] [Related]
17. Cellulose ether treatment inhibits amyloid beta aggregation, neuroinflammation and cognitive deficits in transgenic mouse model of Alzheimer's disease. Ali T; Klein AN; McDonald K; Johansson L; Mukherjee PG; Hallbeck M; Doh-Ura K; Schatzl HM; Gilch S J Neuroinflammation; 2023 Jul; 20(1):177. PubMed ID: 37507761 [TBL] [Abstract][Full Text] [Related]
18. Chotosan improves Aβ1-42-induced cognitive impairment and neuroinflammatory and apoptotic responses through the inhibition of TLR-4/NF-κB signaling in mice. Chen L; Hu L; Zhao J; Hong H; Feng F; Qu W; Liu W J Ethnopharmacol; 2016 Sep; 191():398-407. PubMed ID: 26994819 [TBL] [Abstract][Full Text] [Related]
19. Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer's disease animal model. Cai M; Lee JH; Yang EJ J Neuroinflammation; 2019 Dec; 16(1):264. PubMed ID: 31836020 [TBL] [Abstract][Full Text] [Related]
20. Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis. Wang J; Liu B; Xu Y; Luan H; Wang C; Yang M; Zhao R; Song M; Liu J; Sun L; You J; Wang W; Sun F; Yan H Exp Neurol; 2022 Jan; 347():113870. PubMed ID: 34563511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]